Vivienne C. Ho, Ph.D. - Publications
Affiliations: | 2011 | University of Connecticut, Storrs, CT, United States |
Area:
Cell Biology, Human DevelopmentYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Aghajanian H, Cho YK, Manderfield LJ, Herling MR, Gupta M, Ho VC, Li L, Degenhardt K, Aharonov A, Tzahor E, Epstein JA. Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor. Nature Communications. 7: 12038. PMID 27356767 DOI: 10.1038/Ncomms12038 | 0.555 | |||
2015 | Ho VC, Fong GH. Vasculogenesis and Angiogenesis in VEGF Receptor-1 Deficient Mice. Methods in Molecular Biology (Clifton, N.J.). 1332: 161-76. PMID 26285753 DOI: 10.1007/978-1-4939-2917-7_12 | 0.603 | |||
2014 | Aghajanian H, Choi C, Ho VC, Gupta M, Singh MK, Epstein JA. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways. The Journal of Biological Chemistry. 289: 17971-9. PMID 24825896 DOI: 10.1074/Jbc.M113.544833 | 0.448 | |||
2012 | Grant CL, Caromile LA, Ho V, Durrani K, Rahman MM, Claffey KP, Fong GH, Shapiro LH. Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization. Plos One. 7: e41285. PMID 22815987 DOI: 10.1371/Journal.Pone.0041285 | 0.591 | |||
2012 | Ho VC, Duan LJ, Cronin C, Liang BT, Fong GH. Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice. Circulation. 126: 741-52. PMID 22753193 DOI: 10.1161/Circulationaha.112.091603 | 0.608 | |||
2006 | Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Molecular and Cellular Biology. 26: 8336-46. PMID 16966370 DOI: 10.1128/Mcb.00425-06 | 0.492 | |||
Show low-probability matches. |